Conditions: Difficult to Treat Systemic Lupus Erythematosus
Interventions: Biological: Engineering of chimeric antigen receptors targeting CD19 in allogeneic T cells
Sponsors: Beijing Immunochina Medical Science & Technology Co., Ltd.
Not yet recruiting Conditions: Difficult to Treat Systemic Lupus Erythematosus
Interventions: Biological: Engineering of chimeric antigen receptors targeting CD19 in allogeneic T cells
Sponsors: Beijing Immunochina Medical Science & Technology Co., Ltd.
Not yet recruiting
